Business Context and Reporting Period
Company: Humana Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2001
Business Overview: Humana is a major health benefits company offering coordinated health insurance coverage and related services to employer groups and government-sponsored plans. As of September 30, 2001, the company served approximately 6.4 million members in medical insurance programs and 2.3 million in specialty products. The company operates two primary segments: Commercial (fully insured medical, ASO, specialty) and Government (Medicare+Choice, Medicaid, TRICARE).
Key Financial Metrics
| Metric (in millions) | Three Months Ended Sept 30, 2001 | Nine Months Ended Sept 30, 2001 |
|---|---|---|
| Total Revenues | $2,611 | $7,572 |
| Net Income | $30 | $82 |
| Diluted EPS | $0.18 | $0.49 |
| Operating Cash Flow | N/A | $60 |
| Medical Expense Ratio | 83.3% | 83.5% |
| SG&A Expense Ratio | 15.4% | 15.1% |
| Cash and Equivalents | $592 | $592 |
| Total Debt (Short + Long Term) | $589 | $589 |
Note: Debt figures represent Short-term debt ($271M) and Long-term debt ($318M) as of September 30, 2001.
Material Changes vs. Prior Period
- Revenue: Total revenues decreased 0.9% for the quarter ($2.61B vs. $2.64B) and 5.6% for the nine-month period ($7.57B vs. $8.02B). The decline was driven by reduced membership in non-core Commercial and Government markets, partially offset by the TRICARE acquisition and premium yield improvements.
- Profitability: Net income increased 30% for the quarter ($30M vs. $23M) and 30% for the nine-month period ($82M vs. $63M). This improvement is attributed to pricing discipline, exiting high-cost non-core markets, and benefit reductions in Medicare+Choice.
- Membership: Total medical membership increased 18.0% to 6.43 million. This growth was driven by a 61.1% increase in TRICARE membership (due to the May 2001 acquisition), which offset declines in Commercial (-11.5%), Medicare+Choice (-20.9%), and Medicaid (-21.9%) segments.
- Expense Ratios: The medical expense ratio improved by 90 basis points for the quarter and 120 basis points for the nine-month period compared to the prior year, reflecting the exit of higher-cost markets. SG&A ratios increased slightly due to a higher mix of ASO membership and infrastructure spending.
- Debt Structure: The company issued $300 million in senior notes in August 2001 to repay portions of its revolving credit facility. Short-term debt decreased from $600M at year-end 2000 to $271M, while long-term debt increased to $318M.
Guidance, Outlook, and Risks
Management Commentary & Outlook: Management continues to execute a strategy of eliminating non-core businesses and focusing on core profitable segments. The company expects membership to remain relatively constant for the remainder of 2001, with the exception of a Puerto Rico Medicaid contract transition. Capital expenditures for 2001 are projected at approximately $110 million, primarily for technology initiatives.
Recent Developments: The September 11, 2001 events did not have a material financial impact through the quarter end, though the company is monitoring potential increases in physician visits and prescription drug utilization.
Risks and Contingencies:
- Legal Proceedings: Humana is involved in significant class action litigation, including In re Managed Care Litigation (subscriber and provider tracks) alleging RICO and ERISA violations. A $80 million punitive damages verdict in Chipps v. Humana was overturned on appeal and remanded for a new trial; insurance coverage for punitive damages is uncertain.
- Government Contracts: A significant portion of revenue relies on government programs (Medicare+Choice, Medicaid, TRICARE). Legislative changes or contract non-renewals could materially impact results. One Puerto Rico Medicaid contract (147,000 members) was lost in October 2001.
- Regulatory Environment: The company faces increased scrutiny from state and federal regulators regarding claims practices and utilization management. Potential legislation such as the Patient Bill of Rights (PBOR) could increase costs.
- Accounting Changes: The company will adopt FASB Statement No. 142 effective January 1, 2002, which will cease the amortization of goodwill, potentially impacting future earnings comparisons.
Investor Verification Checklist
- TRICARE Integration: Verify the financial performance and integration costs of the newly acquired TRICARE business (1.2 million members) to ensure it meets profitability projections.
- Legal Exposure: Monitor the status of the Chipps retrial and the class certification rulings in the Managed Care Litigation, as unfavorable outcomes could result in substantial uninsured liabilities.
- Government Contract Renewals: Track the renewal status of the remaining Puerto Rico Medicaid contract (expiring June 2002) and the Florida CMS contract (17% of premium revenue).
- Medical Cost Trends: Assess whether the improved medical expense ratios are sustainable given potential increases in prescription drug costs and utilization following the September 11 events.
- Goodwill Accounting: Review the impact of the upcoming FASB Statement No. 142 adoption on future earnings per share, as goodwill amortization will cease.